The latest news updates from the 2024 Symposium
-
Panel to discuss latest developments in targeting estrogen receptor mutations
Read More: Panel to discuss latest developments in targeting estrogen receptor mutationsAditya Bardia, MD, MPH, will moderate a Friday afternoon session on the latest advances and strategies to target the estrogen receptor gene mutation in breast cancer, including novel drug therapies in development.
-
Special Session provides clinical updates on breast cancer prevention and early detection
Read More: Special Session provides clinical updates on breast cancer prevention and early detectionPrevention, early detection, and interception were the focus of the second Speccial Session on Tuesday at the 2023 SABCS®. Presenter Joanne Kotsopoulos, PhD, discussed use of hormones in patients with BRCA 1 and 2 mutations.
-
Poster Spotlight Session 16: Enhancing Immunotherapy for Triple Negative Breast Cancer: Novel therapies and Biomarkers – Presenter Profile
Read More: Poster Spotlight Session 16: Enhancing Immunotherapy for Triple Negative Breast Cancer: Novel therapies and Biomarkers – Presenter ProfileHans-Christian Kolberg, MD, PhD, discusses a Friday morning poster presentation analyzing the neoadjuvant neoMono trial.
-
Poster Spotlight Session 17: Biomarkers of Response and/or Resistance to Endocrine Based Therapies: Implications for Treatment Approaches – Presenter Profiles
Read More: Poster Spotlight Session 17: Biomarkers of Response and/or Resistance to Endocrine Based Therapies: Implications for Treatment Approaches – Presenter ProfilesSacha Howell, PhD, FRCP, and Angel Guerrero-Zotano, MD, PhD, discuss their Friday morning poster presentations.
-
Poster Spotlight Session 18: Disparate Care Calls for Desperate Measures: Understanding Gaps in Quality of Care and Opportunities to Improve it – Presenter Profiles
Read More: Poster Spotlight Session 18: Disparate Care Calls for Desperate Measures: Understanding Gaps in Quality of Care and Opportunities to Improve it – Presenter ProfilesMalcolm Bevel, PhD, MSPH; Richard J. Bleicher, MD, FACS; and Marcela Mazo-Canola, MD, discuss their Friday morning poster presentations.
-
General Session 1 includes results from HER2CLIMB-02, MONARCH 3 trials
Read More: General Session 1 includes results from HER2CLIMB-02, MONARCH 3 trialsFindings from the HER2CLIMB-02 trial and late-breaking final overall survival results from MONARCH 3 were presented on Wednesday during the first General Session of the 2023 SABCS®.
-
McGuire Memorial Award lecturer, Jack Cuzick, PhD, reviews data on breast cancer prevention
Read More: McGuire Memorial Award lecturer, Jack Cuzick, PhD, reviews data on breast cancer preventionJack Cuzick, PhD, a pioneer in breast cancer prevention research, received the William L. McGuire Memorial Lecture Award on Wednesday.
-
SABCS® Daily Highlights for Thursday, December 7
Read More: SABCS® Daily Highlights for Thursday, December 7SABCS® Program Director Kate Lathrop, MD, shares a few highlights from Thursday’s schedule to help you plan your day, including Poster Spotlight Sessions and notable General Session abstracts.
-
Thursday General Session and Poster Spotlight Session presentations
Read More: Thursday General Session and Poster Spotlight Session presentationsDon’t miss Thursday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
-
Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts and Novel Treatments (People’s Choice) – Presenter Profile
Read More: Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts and Novel Treatments (People’s Choice) – Presenter ProfileFrederick Howard, MD, discusses a Thursday afternoon presentation on whether inflammatory breast cancer is a genomically different type of breast cancer.